Japanese Clinical Practice Guidelines for Management of Clostridioides ( Clostridium) difficile infection
Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico - Document - Gale OneFile: Health and Medicine
A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection | PLOS ONE
A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection | PLOS ONE
![PDF] Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico | Semantic Scholar PDF] Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/12aef0776999df8c0e9132e949cc39a0df4d8fd0/2-Table2-1.png)
PDF] Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico | Semantic Scholar
![Avens Publishing Group - Quantitative Fecal Lactoferrinas a Biomarker for Severe Clostridium difficile Infection in Hospitalized Patients Avens Publishing Group - Quantitative Fecal Lactoferrinas a Biomarker for Severe Clostridium difficile Infection in Hospitalized Patients](https://www.avensonline.org/fulltextarticles/wp-content/uploads/2014/09/JGPC-2373-1133-02-0006-tab1.png)
Avens Publishing Group - Quantitative Fecal Lactoferrinas a Biomarker for Severe Clostridium difficile Infection in Hospitalized Patients
Dr Carlo Tascini I Divisione Malattie Infettive Ospedale Cotugno Napoli 3480623360 c.tascini@gmail.com
![Validation of Clinical Risk Models for Clostridioides difficile-Attributable Outcomes | Antimicrobial Agents and Chemotherapy Validation of Clinical Risk Models for Clostridioides difficile-Attributable Outcomes | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/aac.00676-22/asset/ffd1b838-ca17-46ef-9bb1-44219f5ec32e/assets/images/large/aac.00676-22-f002.jpg)
Validation of Clinical Risk Models for Clostridioides difficile-Attributable Outcomes | Antimicrobial Agents and Chemotherapy
![PDF] Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico | Semantic Scholar PDF] Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/12aef0776999df8c0e9132e949cc39a0df4d8fd0/3-Table3-1.png)
PDF] Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico | Semantic Scholar
![Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy - Jennifer D Tieu, Sarah A Schmidt, Jamie L Miller, Katherine E Kupiec, Grant H Skrepnek, Connie Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy - Jennifer D Tieu, Sarah A Schmidt, Jamie L Miller, Katherine E Kupiec, Grant H Skrepnek, Connie](https://journals.sagepub.com/cms/10.1177/1078155217740945/asset/images/large/10.1177_1078155217740945-fig1.jpeg)